14-day Premium Trial Subscription Try For FreeTry Free
$1.17
-0.0400 (-3.31%)
At Close: May 06, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile
Date Action Amount Person Type
Jan 05, 2024 Buy 100 000 Springer Graig Options
Jan 05, 2024 Buy 25 000 Springer Graig Options
Jan 05, 2024 Buy 25 000 Sarnoff David Options
Jan 05, 2024 Buy 25 000 Pavell Jeff Options
Jan 05, 2024 Buy 25 000 Linsley Wayne Options
Jan 05, 2024 Buy 225 000 Knie Robb Options
Jul 17, 2023 Buy 7 500 Sarnoff David Options
Jul 17, 2023 Buy 20 000 Springer Graig Options
Jul 17, 2023 Buy 7 500 Springer Graig Options
Jul 17, 2023 Buy 40 000 Knie Robb Options
Jul 17, 2023 Buy 7 500 Pavell Jeff Options
Jul 17, 2023 Buy 7 500 Linsley Wayne Options
Dec 13, 2022 Buy 5 075 Pavell Jeff Common Stock
Dec 07, 2022 Buy 0 Pavell Jeff
Dec 07, 2022 Buy 0 Pavell Jeff
Sep 19, 2022 Buy 10 000 Knie Robb Common Stock
Sep 16, 2022 Buy 10 000 Knie Robb Common Stock
Mar 16, 2022 Buy 500 000 Knie Robb Options
Mar 16, 2022 Buy 500 000 Knie Robb Options
Mar 16, 2022 Buy 250 000 Johns Stefanie Options
Mar 16, 2022 Buy 250 000 Johns Stefanie Options
Mar 16, 2022 Buy 40 000 Sarnoff David Options
Mar 16, 2022 Buy 40 000 Sarnoff David Options
Mar 16, 2022 Buy 250 000 Springer Graig Options
Mar 16, 2022 Buy 40 000 Linsley Wayne Options
Mar 16, 2022 Buy 40 000 Linsley Wayne Options
Jan 29, 2021 Buy 150 000 Springer Graig Options
Jan 29, 2021 Buy 33 000 Springer Graig Options
Jan 29, 2021 Buy 33 000 Sarnoff David Options
Jan 29, 2021 Buy 33 000 Mats Vadim Options
Jan 29, 2021 Buy 33 000 Linsley Wayne Options
Jan 29, 2021 Buy 225 000 Knie Robb Options
Jan 29, 2021 Buy 125 000 Johns Stefanie Options
Dec 31, 2020 Buy 0 Aikido Pharma Inc.
Dec 31, 2020 Buy 0 Knie Robb
Sep 08, 2020 Buy 0 Johns Stefanie
Jul 21, 2020 Buy 15 000 Linsley Wayne Options
Jul 21, 2020 Buy 80 000 Knie Robb Options
Jul 21, 2020 Buy 45 000 Springer Graig Options
Jul 21, 2020 Buy 15 000 Springer Graig Options
Jul 21, 2020 Buy 15 000 Sarnoff David Options
Jul 21, 2020 Buy 15 000 Rice Kenneth L Jr Options
Jul 21, 2020 Buy 15 000 Mats Vadim Options
May 26, 2020 Sell 0 Hayes Anthony Common Stock, par value $0.0001
May 26, 2020 Sell 400 000 Hayes Anthony Common Stock, par value $0.0001
Apr 15, 2020 Buy 3 333 Linsley Wayne Common Stock
Apr 15, 2020 Buy 0 Linsley Wayne
Apr 15, 2020 Buy 3 333 Springer Graig Common Stock
Feb 28, 2020 Buy 0 Springer Graig
Dec 31, 2019 Buy 0 Spherix Inc
Dec 31, 2019 Buy 0 Knie Robb
Dec 31, 2019 Buy 0 Hayes Anthony
Dec 24, 2019 Buy 35 000 Sarnoff David Options
Dec 24, 2019 Buy 35 000 Rice Kenneth L Jr Options
Dec 24, 2019 Buy 35 000 Mats Vadim Options
Dec 24, 2019 Buy 250 000 Knie Robb Options
Dec 24, 2019 Buy 35 000 Hayes Anthony Options
Mar 06, 2019 Buy 50 000 Briones David S. Options
Mar 05, 2019 Buy 0 Briones David S.
Feb 20, 2019 Buy 750 000 Poor Kevin Jess Common Stock
Feb 20, 2019 Sell 750 000 Poor Kevin Jess Series A Convertible Preferred Stock
Feb 20, 2019 Buy 15 000 Eitner Matthew D. Common Stock
Feb 20, 2019 Sell 15 000 Eitner Matthew D. Series A Convertible Preferred Stock
Feb 14, 2019 Buy 750 000 Poor Kevin Jess Series A Convertible Preferred Stock
Feb 14, 2019 Buy 0 Eitner Matthew D. Common Stock
Feb 14, 2019 Buy 15 000 Eitner Matthew D. Series A Convertible Preferred Stock
Feb 14, 2019 Buy 0 Ahern James P. Common Stock
Feb 14, 2019 Buy 0 Mats Vadim Common Stock
Feb 14, 2019 Buy 0 Knie Robb Common Stock
Feb 14, 2019 Buy 0 Rice Kenneth L Jr Common Stock
Feb 14, 2019 Buy 0 Rice Kenneth L Jr Common Stock
Feb 14, 2019 Buy 0 Sarnoff David Common Stock
Feb 14, 2019 Buy 0 Hayes Anthony Common Stock
Feb 14, 2019 Buy 0 Hayes Anthony Common Stock
Oct 25, 2017 Buy 187 500 Poor Kevin Jess Warrants
Oct 25, 2017 Buy 3 750 Eitner Matthew D. Warrants
JSON CSV
INSIDER POWER
83.481
Last 76 transactions
Buy: 5 449 991 | Sell: 1 165 000 (Shares)

Based on the 76 latest insides trades, we have calculated the insider power to be positive at a ratio of 83.481.

In total, the insiders bought 5 449 991 and sold 1 165 000 HOTH shares in the last 76 trades.

Click to get the best stock tips daily for free!

About Hoth Therapeutics Inc.

Hoth Therapeutics. Hoth Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for unmet medical needs. It is involved in the development of HT-001, a topical formulation for the treatment of patients with rash and skin disorders associated with initial and repeat courses of tyrosine kinase epidermal growth factor receptor inhibitor therapy; HT-KIT to treat mast-cell derived cancers and anaphylaxis; HT-ALZ for the treatment ... HOTH Profile

Golden Star

Ticker Date Change Price
TMO May 02 0.403% $571.25
STNG May 02 0.699% $71.50
DLR May 02 2.58% $140.15
RF May 02 0.97% $19.64
INVH May 02 0.87% $34.50
SMAR May 02 2.24% $38.39
BIRK May 02 0.650% $44.61
FTSL May 02 0.217% $46.11
VCSH May 02 0.287% $76.71
VRNT May 02 2.44% $30.78
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT